These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 17495597)
21. A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein. Vassiliou G; McPherson R Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1669-75. PubMed ID: 15178567 [TBL] [Abstract][Full Text] [Related]
22. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice. Salerno AG; Patrício PR; Berti JA; Oliveira HC Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759 [TBL] [Abstract][Full Text] [Related]
23. Refocusing on use of cholesteryl ester transfer protein inhibitors. Kastelein JJ Am J Cardiol; 2007 Dec; 100(11 A):n47-52. PubMed ID: 18047853 [TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects. Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058 [TBL] [Abstract][Full Text] [Related]
26. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits. Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610 [TBL] [Abstract][Full Text] [Related]
27. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors. Clark RW Curr Opin Pharmacol; 2006 Apr; 6(2):162-8. PubMed ID: 16487747 [TBL] [Abstract][Full Text] [Related]
28. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus. Oomen PH; van Tol A; Hattori H; Smit AJ; Scheek LM; Dullaart RP Diabet Med; 2005 Jun; 22(6):768-74. PubMed ID: 15910630 [TBL] [Abstract][Full Text] [Related]
29. [The effect of apolipoprotein e polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients]. Chaaba R; Attia N; Hammami S; Smaoui M; Ben Hamda K; Mahjob S; Hammami M Mol Biol (Mosk); 2008; 42(6):931-6. PubMed ID: 19140312 [TBL] [Abstract][Full Text] [Related]
30. Determination of human plasma phospholipid transfer protein mass and activity. Jauhiainen M; Ehnholm C Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933 [TBL] [Abstract][Full Text] [Related]
32. A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology. Eveland SS; Milot DP; Guo Q; Chen Y; Hyland SA; Peterson LB; Jezequel-Sur S; O'Donnell GT; Zuck PD; Ferrer M; Strulovici B; Wagner JA; Tanaka WK; Hilliard DA; Laterza O; Wright SD; Sparrow CP; Anderson MS Anal Biochem; 2007 Sep; 368(2):239-49. PubMed ID: 17601482 [TBL] [Abstract][Full Text] [Related]
33. Induction of fatty liver in cows by ethionine administration and concomitant decreases of serum apolipoproteins B-100 and A-I concentrations. Uchida E; Katoh N; Takahashi K Am J Vet Res; 1992 Nov; 53(11):2035-42. PubMed ID: 1466499 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer. Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886 [TBL] [Abstract][Full Text] [Related]
35. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Kontush A; Chapman MJ Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945 [TBL] [Abstract][Full Text] [Related]
36. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Schaefer EJ; Asztalos BF Am J Cardiol; 2007 Dec; 100(11 A):n25-31. PubMed ID: 18047849 [TBL] [Abstract][Full Text] [Related]
37. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema. Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590 [TBL] [Abstract][Full Text] [Related]
38. Phospholipid transfer protein is present in human tear fluid. Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430 [TBL] [Abstract][Full Text] [Related]
39. Raisins and walking alter appetite hormones and plasma lipids by modifications in lipoprotein metabolism and up-regulation of the low-density lipoprotein receptor. Puglisi MJ; Mutungi G; Brun PJ; McGrane MM; Labonte C; Volek JS; Fernandez ML Metabolism; 2009 Jan; 58(1):120-8. PubMed ID: 19059539 [TBL] [Abstract][Full Text] [Related]
40. Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to go. Sniderman AD Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):116-23. PubMed ID: 17940429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]